David W. Salzman, Ph.D.

Affiliations: 
Gatehouse Bio 
Area:
RNA, microRNA, molecular biology, genetics, radiation therapy, translational science
Google:
"David Salzman"
Mean distance: (not calculated yet)
 
Cross-listing: Neurotree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Jung SY, Malhotra P, Nguyen KC, et al. (2019) The KRAS-variant and its impact on normal breast epithelial cell biology. Cell Death and Differentiation
McCampbell A, Cole T, Wegener AJ, et al. (2018) Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models. The Journal of Clinical Investigation
Gautheret D, Taube JH, Mani SA, et al. (2016) Erratum: The Non-Coding RNA Journal Club: Highlights on Recent Papers-4. Non-Coding RNA 2016, 2, 9. Non-Coding Rna. 2
Gautheret D, Taube JH, Mani SA, et al. (2016) The Non-Coding RNA Journal Club: Highlights on Recent Papers-4. Non-Coding Rna. 2
Salzman DW, Nakamura K, Nallur S, et al. (2016) miR-34 activity is modulated through 5'-end phosphorylation in response to DNA damage. Nature Communications. 7: 10954
McVeigh TP, Jung SY, Kerin MJ, et al. (2015) Estrogen withdrawal, increased breast cancer risk and the KRAS-variant. Cell Cycle (Georgetown, Tex.). 14: 2091-9
Saridaki Z, Weidhaas JB, Lenz HJ, et al. (2014) A let-7 microRNA-binding site polymorphism in KRAS predicts improved outcome in patients with metastatic colorectal cancer treated with salvage cetuximab/panitumumab monotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 4499-510
Dorairaj JJ, Salzman DW, Wall D, et al. (2014) A germline mutation in the BRCA1 3'UTR predicts Stage IV breast cancer. Bmc Cancer. 14: 421
Salzman DW, Weidhaas JB. (2013) SNPing cancer in the bud: microRNA and microRNA-target site polymorphisms as diagnostic and prognostic biomarkers in cancer. Pharmacology & Therapeutics. 137: 55-63
Salzman DW, Weidhaas JB. (2011) miRNAs in the spotlight: Making 'silent' mutations speak up. Nature Medicine. 17: 934-5
See more...